Trials / Completed
CompletedNCT01161615
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 350 (actual)
- Sponsor
- MEDRx USA, Inc. · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MRX-7EAT | Application of up to two patches for up to 7 days. |
| DRUG | Placebo | Application of up to two patches for up to 7 days. |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-07-13
- Last updated
- 2018-01-17
Locations
35 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01161615. Inclusion in this directory is not an endorsement.